Robeco Institutional Asset Management B.V. Sells 16,838 Shares of Teleflex Incorporated $TFX

Robeco Institutional Asset Management B.V. decreased its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 85.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,797 shares of the medical technology company's stock after selling 16,838 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Teleflex were worth $331,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in TFX. Thurston Springer Miller Herd & Titak Inc. raised its position in Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 153 shares during the period. Banque Cantonale Vaudoise purchased a new stake in shares of Teleflex during the 1st quarter valued at $27,000. Costello Asset Management INC purchased a new position in Teleflex in the 1st quarter worth $28,000. Brooklyn Investment Group raised its stake in shares of Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock valued at $29,000 after buying an additional 150 shares during the last quarter. Finally, Allworth Financial LP raised its stake in shares of Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock valued at $34,000 after buying an additional 212 shares during the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Royal Bank Of Canada raised their target price on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Zacks Research lowered shares of Teleflex from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, September 30th. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research note on Monday, September 15th. Wells Fargo & Company lowered their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Finally, Mizuho upped their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. One analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Teleflex currently has an average rating of "Reduce" and an average target price of $141.57.

Insiders Place Their Bets

In other news, Director Jaewon Ryu purchased 1,500 shares of the company's stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average price of $115.00 per share, with a total value of $172,500.00. Following the purchase, the director directly owned 3,727 shares of the company's stock, valued at approximately $428,605. This represents a 67.36% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Andrew A. Krakauer bought 1,000 shares of the company's stock in a transaction dated Tuesday, August 5th. The stock was bought at an average cost of $115.25 per share, with a total value of $115,250.00. Following the transaction, the director directly owned 7,192 shares in the company, valued at approximately $828,878. The trade was a 16.15% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 5,500 shares of company stock worth $633,590. 1.40% of the stock is owned by company insiders.

Teleflex Stock Up 1.3%

TFX stock opened at $128.50 on Thursday. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $241.41. The company's 50 day simple moving average is $124.12 and its 200-day simple moving average is $124.54. The firm has a market capitalization of $5.68 billion, a PE ratio of 30.24, a P/E/G ratio of 1.77 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. During the same quarter last year, the business earned $3.42 earnings per share. Teleflex's revenue was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio (DPR) is currently 32.00%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.